Why the study?
Does intracisternal 6-hydroxydopamine prevent the rise in blood pressure and plasma noradrenaline in a rat model of renovascular hypertension?
Does intracisternal 6-hydroxydopamine prevent the rise in blood pressure and plasma noradrenaline in a rat model of renovascular hypertension?
Increased peripheral sympathetic activity in the one-kidney Goldblatt model of experimental hypertension is at least in part centrally mediated.
Answers are grounded in this paper and cite their sources.
Supports central mediation of sympathetic activation in renovascular hypertension models; leaves open clinical translation.
Plasma noradrenaline concentrations and dopamine beta-hydroxylase activity have been measured at various stages in the development of hypertension in the one-kidney Goldblatt rat (unilateral renal arterial constriction and contralateral nephrectomy). 2. Although plasma noradrenaline concentrations were significantly elevated from control values at 7, 14 and 28 days, plasma dopamine beta-hydroxylase activity was not significantly different from control values except at 24 h. 3. These findings suggest that peripheral sympathetic activity is increased in the one-kidney Goldblatt model of experimental hypertension but that plasma dopamine beta-hydroxylase activity is poor index of this increase. 4. Both the rise in blood pressure and the rise in plasma noradrenaline concentrations were prevented by pretreatment with intracisternal 6-hydroxydopamine, suggesting that the increased sympathetic activity is at least in part centrally mediated.
No takes yet. Share an insight, caveat, or question.
Dargie et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: